Cargando…

Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) is a major health threat around the world and is characterized by dysbiosis. Primary bile acids are synthesized in the liver and converted into secondary bile acids by gut microbiota. Recent studies support the role of bile acids in modulating dysbiosis and N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Caihua, Zhu, Chunpeng, Shao, Liming, Ye, Jun, Shen, Yimin, Ren, Yuezhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613006/ https://www.ncbi.nlm.nih.gov/pubmed/31341422 http://dx.doi.org/10.1155/2019/7659509

Ejemplares similares

A comprehensive look at the role of hyperlipidemia in promoting colorectal cancer liver metastasis
por: Shen, Yimin, et al.
Publicado: (2018)

Elevated level of mitochondrial reactive oxygen species via fatty acid β-oxidation in cancer stem cells promotes cancer metastasis by inducing epithelial–mesenchymal transition
por: Wang, Caihua, et al.
Publicado: (2019)

Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease
por: Mouzaki, Marialena, et al.
Publicado: (2016)

Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
por: Xue, Rui, et al.
Publicado: (2021)

Linking Nonalcoholic Fatty Liver Disease and Brain Disease: Focusing on Bile Acid Signaling
por: Ren, Zi-Lin, et al.
Publicado: (2022)

Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
por: Arab, Juan P., et al.
Publicado: (2016)

Prognostic significance of chemokines CCL11 and CCL5 modulated by low-density lipoprotein cholesterol in colon cancer patients with normal body mass index
por: Wang, Caihua, et al.
Publicado: (2021)

Bile acid metabolism and signaling: potential therapeutic target for nonalcoholic fatty liver disease
por: Lin, Chuan-Hao, et al.
Publicado: (2018)

Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications
por: Fang, Jie, et al.
Publicado: (2022)

Zhuyu Pill Alleviates Nonalcoholic Fatty Liver Disease by Regulating Bile Acid Metabolism through the Gut–Liver Axis
por: Xu, Lu, et al.
Publicado: (2023)

Role of bioactive fatty acids in nonalcoholic fatty liver disease
por: Juárez-Hernández, Eva, et al.
Publicado: (2016)

Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates
por: Khan, Ashiq, et al.
Publicado: (2021)

Bile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver Disease
por: Kim, Sun-Gi, et al.
Publicado: (2016)

Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism
por: Lu, Yifei, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance
por: Da Silva, Hannah E., et al.
Publicado: (2018)

Fatty liver diseases, bile acids, and FXR
por: Zhu, Yan, et al.
Publicado: (2016)

Disease-Associated Gut Microbiota Reduces the Profile of Secondary Bile Acids in Pediatric Nonalcoholic Fatty Liver Disease
por: Yu, Jiake, et al.
Publicado: (2021)

Cholesterol-binding translocator protein TSPO regulates steatosis and bile acid synthesis in nonalcoholic fatty liver disease
por: Li, Yuchang, et al.
Publicado: (2021)

Correlation between serum total bile acid and nonalcoholic fatty liver disease: A cross-sectional study
por: Chen, Yingying, et al.
Publicado: (2022)

Serum Bile Acid, Vitamin E, and Serotonin Metabolites Are Associated With Future Liver‐Related Events in Nonalcoholic Fatty Liver Disease
por: Wegermann, Kara, et al.
Publicado: (2021)

Association of Serum and Fecal Bile Acid Patterns With Liver Fibrosis in Biopsy-Proven Nonalcoholic Fatty Liver Disease: An Observational Study
por: Kasai, Yuki, et al.
Publicado: (2022)

Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease
por: Makri, Evangelia, et al.
Publicado: (2016)

Characteristics of bile acid composition in high fat diet-induced nonalcoholic fatty liver disease in obese diabetic rats
por: Nakade, Yukiomi, et al.
Publicado: (2021)

Ilexsaponin A(1) Ameliorates Diet-Induced Nonalcoholic Fatty Liver Disease by Regulating Bile Acid Metabolism in Mice
por: Zhao, Wen-wen, et al.
Publicado: (2021)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
por: Wang, Xin, et al.
Publicado: (2011)

Role of Mitochondria in Nonalcoholic Fatty Liver Disease
por: Nassir, Fatiha, et al.
Publicado: (2014)

The Role of Phytosterols in Nonalcoholic Fatty Liver Disease
por: Frasinariu, Otilia, et al.
Publicado: (2022)

The role of complement in nonalcoholic fatty liver disease
por: Guo, Zhenya, et al.
Publicado: (2022)

Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan
por: Tsai, Ming-Chao, et al.
Publicado: (2020)

Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis
por: Kuraji, Ryutaro, et al.
Publicado: (2023)

Distinct Dose-Dependent Association of Free Fatty Acids with Diabetes Development in Nonalcoholic Fatty Liver Disease Patients
por: Li, Fuxi, et al.
Publicado: (2021)

Macrophage metabolism in nonalcoholic fatty liver disease
por: Zhang, Wenhui, et al.
Publicado: (2023)

The Role of Skeletal Muscle in Development of Nonalcoholic Fatty Liver Disease
por: Moon, Jun Sung, et al.
Publicado: (2013)

Role of Docosahexaenoic Acid Treatment in Improving Liver Histology in Pediatric Nonalcoholic Fatty Liver Disease
por: Nobili, Valerio, et al.
Publicado: (2014)

Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies
por: Huang, Yue Ye, et al.
Publicado: (2013)

Protective role of arnebin-1 in rats with nonalcoholic fatty liver disease
por: Yang, Weijia, et al.
Publicado: (2019)

The Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease
por: Roychowdhury, Sanjoy, et al.
Publicado: (2018)

Role of cenicriviroc in the management of nonalcoholic fatty liver disease
por: Neokosmidis, Georgios, et al.
Publicado: (2018)

Nonalcoholic Fatty Liver Disease in Diabetics: The Role of Hepatologist
por: Khandelwal, Reshu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_36o8q3mnvh1ckjesftfg42rh8q